The Food and Drug Administration has approved a  diagnostic test that health providers may use to diagnose COVID-19, Influenza A, and Influenza B.

This is the third such combination diagnostic test authorized by the FDA.  The FDA says having such combination tests will mean that patients may only need one test to determine what they have and how to treat it, so it will be more comfortable for patients.  It also means fewer test supplies will be needed, and has been seen during this COVID-19 pandemic, test supplies for COVID–swabs, testing agents–have sometimes been in short supply.